The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
C-reactive protein, procalcitonin, D-dimer, and ferritin in severe coronavirus disease-2019: a meta-analysis
Open accessAbstract
Background: Patients critically ill with coronavirus disease-2019 (COVID-19) feature hyperinflammation, and the associated biomarkers may be beneficial for risk stratification. We aimed to investigate the association between several biomarkers, including serum C-reactive protein (CRP), procalcitonin (PCT), D-dimer, and serum ferritin, and COVID-19 severity. Methods: We performed a comprehensive systematic literature search through electronic databases. The outcome of interest for this study was the composite poor outcome, which comprises mortality, acute respiratory distress syndrome, need for care in an intensive care unit, and severe COVID-19. Results: A total of 5350 patients were pooled from 25 studies. Elevated CRP was associated with an increased composite poor outcome [risk ratio (RR) 1.84 (1.45, 2.33), p < 0.001; I 2: 96%] and its severe COVID-19 (RR 1.41; I 2: 93%) subgroup. A CRP ⩾10 mg/L has a 51% sensitivity, 88% specificity, likelihood ratio (LR) + of 4.1, LR- of 0.5, and an area under curve (AUC) of 0.84. An elevated PCT was associated with an increased composite poor outcome [RR 3.92 (2.42, 6.35), p < 0.001; I 2: 85%] and its mortality (RR 6.26; I 2: 96%) and severe COVID-19 (RR 3.93; I 2: 63%) subgroups. A PCT ⩾0.5 ng/ml has an 88% sensitivity, 68% specificity, LR+ of 2.7, LR- of 0.2, and an AUC of 0.88. An elevated D-dimer was associated with an increased composite poor outcome [RR 2.93 (2.14, 4.01), p < 0.001; I 2: 77%], including its mortality (RR 4.15; I 2: 83%) and severe COVID-19 (RR 2.42; I 2: 58%) subgroups. A D-dimer >0.5 mg/L has a 58% sensitivity, 69% specificity, LR+ of 1.8, LR- of 0.6, and an AUC of 0.69. Patients with a composite poor outcome had a higher serum ferritin with a standardized mean difference of 0.90 (0.64, 1.15), p < 0.0001; I 2: 76%. Conclusion: This meta-analysis showed that an elevated serum CRP, PCT, D-dimer, and ferritin were associated with a poor outcome in COVID-19. The reviews of this paper are available via the supplemental material section.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical characteristics of coronavirus disease 2019 in China
Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., Liu, L., Shan, H., Lei, C.-L., Hui, D. S. C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2002032 · Cited by 30,246
Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., Xiang, J., Wang, Y., Song, B., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30566-3 · Cited by 27,263
Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., Wei, Y., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30211-7 · Cited by 21,415
Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., Wang, B., Xiang, H., Cheng, Z., Xiong, Y., et al. (2020) · JAMA · doi:10.1001/jama.2020.1585 · Cited by 20,148
La certeza de lo impredecible: Cultura Educación y Sociedad en tiempos de COVID19
Martínez González, M. (2020) · DSPACE System - Metalibrary (University of the Coast) · Cited by 18,463
COVID-19: consider cytokine storm syndromes and immunosuppression
Mehta, P., McAuley, D. F., Brown, M., Sanchez, E., Tattersall, R. S., & Manson, J. J. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30628-0 · Cited by 9,664
Wu, C., Chen, X., Cai, Y., Xia, J., Zhou, X., Xu, S., Huang, H., Zhang, L., Zhou, X., Du, C., et al. (2020) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2020.0994 · Cited by 8,249
Ruan, Q., Yang, K., Wang, W., Jiang, L., & Song, J. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-05991-x · Cited by 4,898
Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China
Qin, C., Zhou, L., Hu, Z., Zhang, S., Yang, S., Tao, Y., Xie, C., Ma, K., Shang, K., Wang, W., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa248 · Cited by 4,775
Clinical and immunological features of severe and moderate coronavirus disease 2019
Chen, G., Wu, D., Guo, W., Cao, Y., Huang, D., Wang, H., Wang, T., Zhang, X., Chen, H., Yu, H., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci137244 · Cited by 4,750
Clinical characteristics of 140 patients infected with SARS‐CoV‐2 in Wuhan, China
Zhang, J.-J., Dong, X., Cao, Y.-Y., Yuan, Y.-D., Yang, Y.-B., Yan, Y.-Q., Akdis, C. A., & Gao, Y.-D. (2020) · Allergy · doi:10.1111/all.14238 · Cited by 4,004
Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study
Chen, T., Wu, D., Chen, H., Yan, W., Yang, D., Chen, G., Ma, K., Xu, D., Yu, H., Wang, H., et al. (2020) · BMJ · doi:10.1136/bmj.m1091 · Cited by 3,903
Role of C-Reactive Protein at Sites of Inflammation and Infection
Sproston, N. R., & Ashworth, J. J. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00754 · Cited by 3,029
ISTH interim guidance on recognition and management of coagulopathy in COVID‐19
Thachil, J., Tang, N., Gando, S., Falanga, A., Cattaneo, M., Levi, M., Clark, C., & Iba, T. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14810 · Cited by 1,925
Liu, J., Li, S., Liu, J., Liang, B., Wang, X., Wang, H., Li, W., Tong, Q., Yi, J., Zhao, L., et al. (2020) · eBioMedicine · doi:10.1016/j.ebiom.2020.102763 · Cited by 1,702
COVID-19 illness in native and immunosuppressed states: A clinical–therapeutic staging proposal
Siddiqi, H. K., & Mehra, M. R. (2020) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2020.03.012 · Cited by 1,701
Adult haemophagocytic syndrome
Ramos-Casals, M., Brito-Zerón, P., López-Guillermo, A., Khamashta, M. A., & Bosch, X. (2014) · The Lancet · doi:10.1016/s0140-6736(13)61048-x · Cited by 1,442
World Health Organization (2020) · Pediatria i Medycyna Rodzinna · doi:10.15557/pimr.2020.0003 · Cited by 1,329
Zhang, W., Zhao, Y., Zhang, F., Wang, Q., Li, T., Liu, Z., Wang, J., Qin, Y., Zhang, X., Yan, X., et al. (2020) · Clinical Immunology · doi:10.1016/j.clim.2020.108393 · Cited by 1,266
Prognostic value of interleukin-6, C-reactive protein, and procalcitonin in patients with COVID-19
Liu, F., Li, L., Xu, M., Wu, J., Luo, D., Zhu, Y., Li, B., Song, X., & Zhou, X. (2020) · Journal of Clinical Virology · doi:10.1016/j.jcv.2020.104370 · Cited by 1,141
Clinical Features and Treatment of COVID-19 Patients in Northeast Chongqing
Wan, S., Xiang, Y., Fang, W., Zheng, Y., Li, B., Hu, Y., Lang, C., Huang, D., Sun, Q., Xiong, Y., et al. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25783 · Cited by 982
Huang, I., Lim, M. A., & Pranata, R. (2020) · Diabetes & Metabolic Syndrome: Clinical Research & Reviews · doi:10.1016/j.dsx.2020.04.018 · Cited by 933
Self-citationLin, L., Lu, L., Cao, W., & Li, T. (2020) · Emerging Microbes & Infections · doi:10.1080/22221751.2020.1746199 · Cited by 914
Levi, M., & van der Poll, T. (2017) · Thrombosis Research · doi:10.1016/j.thromres.2016.11.007 · Cited by 846
Clinical features and short-term outcomes of 221 patients with COVID-19 in Wuhan, China
Zhang, G., Hu, C., Luo, L., Fang, F., Chen, Y., Li, J., Peng, Z., & Pan, H. (2020) · Journal of Clinical Virology · doi:10.1016/j.jcv.2020.104364 · Cited by 694
Lymphopenia in severe coronavirus disease-2019 (COVID-19): systematic review and meta-analysis
Huang, I., & Pranata, R. (2020) · Journal of Intensive Care · doi:10.1186/s40560-020-00453-4 · Cited by 662
Self-citationProcalcitonin in patients with severe coronavirus disease 2019 (COVID-19): A meta-analysis
Lippi, G., & Plebani, M. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2020.03.004 · Cited by 652
Procalcitonin for diagnosis of infection and guide to antibiotic decisions: past, present and future
Schuetz, P., Albrich, W., & Mueller, B. (2011) · BMC Medicine · doi:10.1186/1741-7015-9-107 · Cited by 528
COVID‐19 in a designated infectious diseases hospital outside Hubei Province, China
Cai, Q., Huang, D., Ou, P., Yu, H., Zhu, Z., Xia, Z., Su, Y., Ma, Z., Zhang, Y., Li, Z., et al. (2020) · Allergy · doi:10.1111/all.14309 · Cited by 502
Cao, J., Tu, W.-J., Cheng, W., Yu, L., Liu, Y.-K., Hu, X., & Liu, Q. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa243 · Cited by 495
Schuetz, P., Wirz, Y., Sager, R., Christ-Crain, M., Stolz, D., Tamm, M., Bouadma, L., Luyt, C. E., Wolff, M., Chastre, J., et al. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30592-3 · Cited by 486
Hu, L., Chen, S., Fu, Y., Gao, Z., Long, H., Ren, H.-W., Zuo, Y., Wang, J., Li, H., Xu, Q.-B., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa539 · Cited by 392
Pranata, R., Huang, I., Lim, M. A., Wahjoepramono, E. J., & July, J. (2020) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2020.104949 · Cited by 366
Self-citationSong, J., Park, D. W., Moon, S., Cho, H.-J., Park, J. H., Seok, H., & Choi, W. S. (2019) · BMC Infectious Diseases · doi:10.1186/s12879-019-4618-7 · Cited by 348
Pranata, R., Lim, M. A., Huang, I., Raharjo, S. B., & Lukito, A. A. (2020) · Journal of the Renin-Angiotensin-Aldosterone System · doi:10.1177/1470320320926899 · Cited by 346
Self-citationMacrophage Activation-Like Syndrome: A Distinct Entity Leading to Early Death in Sepsis
Karakike, E., & Giamarellos-Bourboulis, E. J. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00055 · Cited by 304
Tabata, S., Imai, K., Kawano, S., Ikeda, M., Kodama, T., Miyoshi, K., Obinata, H., Mimura, S., Kodera, T., Kitagaki, M., et al. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30482-5 · Cited by 296
Procalcitonin to Distinguish Viral From Bacterial Pneumonia: A Systematic Review and Meta-analysis
Kamat, I. S., Ramachandran, V., Eswaran, H., Guffey, D., & Musher, D. M. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciz545 · Cited by 272
Serum Amyloid A is a biomarker of severe Coronavirus Disease and poor prognosis
Li, H., Xiang, X., Ren, H., Xu, L., Zhao, L., Chen, X., Long, H., Wang, Q., & Wu, Q. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.03.035 · Cited by 255
Use of Corticosteroids in Coronavirus Disease 2019 Pneumonia: A Systematic Review of the Literature
Veronese, N., Demurtas, J., Yang, L., Tonelli, R., Barbagallo, M., Lopalco, P., Lagolio, E., Celotto, S., Pizzol, D., Zou, L., et al. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.00170 · Cited by 188
Predictors of fatality including radiographic findings in adults with COVID-19
Li, K., Chen, D., Chen, S., Feng, Y., Chang, C., Wang, Z., Wang, N., & Zhen, G. (2020) · Respiratory Research · doi:10.1186/s12931-020-01411-2 · Cited by 142
Koozi, H., Lengquist, M., & Frigyesi, A. (2019) · Journal of Critical Care · doi:10.1016/j.jcrc.2019.12.009 · Cited by 115
Pranata, R., Huang, I., Lukito, A. A., & Raharjo, S. B. (2020) · Postgraduate Medical Journal · doi:10.1136/postgradmedj-2020-137884 · Cited by 115
Self-citationRyoo, S. M., Han, K. S., Ahn, S., Shin, T. G., Hwang, S. Y., Chung, S. P., Hwang, Y. J., Park, Y. S., Jo, Y. H., Chang, H., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-42972-7 · Cited by 106
Effect of chronic obstructive pulmonary disease and smoking on the outcome of COVID-19
Pranata, R., Soeroto, A. Y., Huang, I., Lim, M. A., Santoso, P., Permana, H., & Lukito, A. A. (2020) · The International Journal of Tuberculosis and Lung Disease · doi:10.5588/ijtld.20.0278 · Cited by 101
Self-citationCOVID-19 Myocarditis and Severity Factors: An Adult Cohort StudyPreprint
Ma, K., Liu, Z., Cao, C.-F., Liu, M.-K., Liao, J., Zou, J.-B., Kong, L., Wan, K.-Q., Zhang, J., Wang, Q., et al. (2020) · medRxiv · doi:10.1101/2020.03.19.20034124 · Cited by 75
Miguel-Bayarri, V., Casanoves-Laparra, E. B., Beneyto, L. A. P., Chinesta, S. S., Martín-Osorio, L. F., Tormo-Calandín, C., & Bautista‐Rentero, D. (2012) · Medicina Intensiva · doi:10.1016/j.medin.2012.01.014 · Cited by 62
The Potential Role of IL-6 in Monitoring Coronavirus Disease 2019Preprint
Liu, T., Zhang, J., Yang, Y., Zhang, L., Ma, H., Li, Z., Zhang, J., Cheng, J., Zhang, X., Wu, G., et al. (2020) · SSRN Electronic Journal · doi:10.2139/ssrn.3548761 · Cited by 59
Characteristics of patients with COVID-19 during epidemic ongoing outbreak in Wuhan, ChinaPreprint
Luo, X., Xia, H., Yang, W., Wang, B., Guo, T., Xiong, J., Jiang, Z., Liu, Y., Yan, X., Zhou, W., et al. (2020) · medRxiv · doi:10.1101/2020.03.19.20033175 · Cited by 54
Creamer, A. W., Kent, A. E., & Albur, M. (2019) · Breathe · doi:10.1183/20734735.0258-2019 · Cited by 53
Miguel-Bayarri, V., Casanoves-Laparra, E. B., Beneyto, L. A. P., Chinesta, S. S., Martín-Osorio, L. F., Tormo-Calandín, C., & Bautista‐Rentero, D. (2012) · Medicina Intensiva (English Edition) · doi:10.1016/j.medine.2012.10.008 · Cited by 52
Clinical Characteristics Predicting Progression of COVID-19Preprint
Ji, D., Zhang, D., Zhu, C., Xu, Z., Zhao, P., Zhang, M., Zhang, L., Cheng, G. Y.-M., Wang, Y., Yang, G., et al. (2020) · SSRN Electronic Journal · doi:10.2139/ssrn.3539674 · Cited by 32
Cited by
Risk factors for severe and critically ill COVID‐19 patients: A review
Gao, Y., Ding, M., Dong, X., Zhang, J., Kursat Azkur, A., Azkur, D., Gan, H., Sun, Y., Fu, W., Li, W., et al. (2021) · Allergy · doi:10.1111/all.14657 · Cited by 1,402
Torrente-Rodríguez, R. M., Lukas, H., Tu, J., Min, J., Yang, Y., Xu, C., Rossiter, H. B., & Gao, W. (2020) · Matter · doi:10.1016/j.matt.2020.09.027 · Cited by 490
COVID-19 and multiorgan failure: A narrative review on potential mechanisms
Mokhtari, T., Hassani, F., Ghaffari, N., Ebrahimi, B., Yarahmadi, A., & Hassanzadeh, G. (2020) · Journal of Molecular Histology · doi:10.1007/s10735-020-09915-3 · Cited by 439
Increased antimicrobial resistance during the COVID-19 pandemic
Lai, C.-C., Chen, S.-Y., Ko, W.-C., & Hsueh, P.-R. (2021) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2021.106324 · Cited by 436
Tuty Kuswardhani, R. A., Henrina, J., Pranata, R., Anthonius Lim, M., Lawrensia, S., & Suastika, K. (2020) · Diabetes & Metabolic Syndrome: Clinical Research & Reviews · doi:10.1016/j.dsx.2020.10.022 · Cited by 294
Self-citation
Metadata
- Authors
- Huang, I., Pranata, R., Lim, M. A., Oehadian, A., & Alisjahbana, B.
- Venue
- Therapeutic Advances in Respiratory Disease
- Publisher
- SAGE Publications
- Published
- 2020-01
- Volume
- 14
- Pages
- 1753466620937175-1753466620937175
- ISSN
- 1753-4658 (ISSN-L)
- 1753-4666
- OpenAlex
- W3040395637
- Cited by
- 604
- References
- 52
- FWCI
- 7.34
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.